Trial Profile
Real-world comperative study of untreated non-valvulas atrial fibrillation patients and those treated with apixaban, dabigatran, rivaroxaban, or warfarin
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Apr 2017
Price :
$35
*
At a glance
- Drugs Apixaban (Primary) ; Dabigatran etexilate; Rivaroxaban; Warfarin
- Indications Stroke
- Focus Therapeutic Use
- 11 Apr 2017 New trial record